Trial intelligence / Profile preview

Renal Protective Effect of Intravenous Amino Acids in Unilateral Nephrectomy

TCTR20251014005Phase 4Recruiting

Sponsor
Chulalongkorn University
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Travesol in acute kidney failure (AKF), sponsored by Chulalongkorn University. Started Nov 2025; status: recruiting.

02

Drugs

Travesol
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on TCTR20251014005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251014005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call